Clinical Trial Detail

NCT ID NCT04297605
Title Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Rochester
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab + Pemetrexed Disodium

Nab-paclitaxel + Pembrolizumab

Age Groups: senior adult

No variant requirements are available.